Introduction: Concentrations of 1,25-hydroxyvitamin D have been positively associated with dietary sodium and salt sensitivity (SS) of blood pressure (BP), and inversely with plasma renin activity (PRA). We investigated the association between PRA and 25-hydroxyvitamin D (25OHD), the most clinically relevant vitamin D metabolite, and whether 25OHD associates with SS of BP in renin phenotypes of hypertension. Methods: We performed cross-sectional analyses on 223 Caucasian subjects with hypertension maintained in high and low dietary sodium balance. Subjects were distinguished as having low-renin (LR) or normal-renin (NR) hypertension. Multivariable linear regression was used to evaluate adjusted relationships. Results: Increasing 25OHD concentrations were inversely associated with PRA (p < 0.05) on both salt diets. Furthermore, 25OHD was associated with SS of BP in LR hypertension (b = 0.62, p = 0.04), but not in NR hypertension (b = 0.06, p = 0.59). In an adjusted multivariable interaction model, renin status (LR vs. NR) was a significant effect modifier of the relationship between 25OHD and SS of BP (p = 0.04). Conclusions: Our findings suggest that 25OHD is inversely associated with PRA and positively associated with SS of BP in LR hypertension subjects. These results extend and support prior evidence indicating an interaction between dietary sodium, the RAS, and vitamin D that influences BP in hypertension.
Introduction
Salt sensitivity (SS) of blood pressure (BP) in hypertension (HTN) is a well-described phenotype whose pathophysiology remains incompletely understood. 1, 2 Plasma renin activity (PRA) and SS of BP have both been linked to 1,25-dihydroxyvitamin D (1,25OHD) concentrations; [3] [4] [5] [6] however, the clinically relevant vitamin D metabolite 25-hydroxyvitamin D (25OHD) has not been investigated in the same manner.
Prior work has recognised intracellular calcium concentrations as an important determinant of BP responsiveness and HTN. 7 Resnick and others demonstrated that the flux of calcium into vascular smooth muscle cells may be facilitated by 1,25OHD; broadening the pathophysiology of SS in HTN to include considerations of salt-regulatory and calcium-regulatory hormones. 8, 9 An inverse relationship between circulating 1,25OHD and plasma renin activity (PRA) has been observed, whereby increased production of 1,25OHD was associated with lower PRA. [3] [4] [5] Furthermore, dietary salt loading was associated with an increase in circulating 1,25OHD concentrations; individuals with the greatest salt-induced increases in 1,25OHD concentrations were those who exhibited the greatest BP response to salt. 4, 5, [10] [11] [12] Some studies suggested that these continuous relationships between indices of calcium homeostasis and BP were restricted to individuals with a low-renin phenotype of HTN. 13, 14 Since intracellular calcium concentrations are also associated with an inhibition of renin secretion in juxtaglomerular cells, 15, 16 prior investigators hypothesised that the pressor response to salt in HTN was dependent on the interplay between vitamin D, salt, and the renin-angiotensin system (RAS), resulting in regulation of PRA, vascular smooth muscle intracellular calcium, and thus determination of BP responses to salt. 5, 12 Since those studies were published about 20 years ago, little research has continued to explore the role of vitamin D in the pathophysiology of SS in HTN. In the last decade, Li et al. provided convincing support for vitamin D as a renin antagonist in animal experiments. [17] [18] [19] [20] We recently demonstrated an inverse relationship between 25OHD and vascular RAS activity, 21, 22 supporting previous observations that vitamin D may inhibit the RAS. 3, 5, 18 Given the epidemic prevalence of 25OHD deficiency worldwide [23] [24] [25] in concert with evidence of an inverse association between vitamin D and renin, 3, 4, 17, 18, 21 we investigated the association between 25OHD and PRA under dietary sodium balance in HTN. Since vitamin D is associated with SS of BP, 4, 5, [10] [11] [12] 26 and BP regulation in low-renin HTN, 13, 14 we also evaluated whether associations between the precursor substrate 25OHD and the pressor response to salt differed according to renin phenotypes of HTN.
Methods

Study population
This cross-sectional analysis was performed on data gathered from subjects studied in the International Hypertensive Pathotype (HyperPath) Consortium, which has been described previously. 21, 27, 28 The HyperPath Consortium has been an ongoing, multisite study, aimed at investigating the pathophysiologic and genotypic mechanisms involved in hypertension and cardiovascular diseases. Participants were studied at four collaborating centres: Brigham and Women's Hospital (Boston, MA, USA), University of Utah Medical Center (Salt Lake City, UT, USA), Vanderbilt University Hospital (Nashville, TN, USA), and Hôpital Européen Georges Pompidou (Paris, France).
Subjects with chronic kidney disease, coronary heart disease, heart failure, suggested or known causes of secondary hypertension, and active malignancy were not enrolled in the HyperPath study. Enrolled subjects were classified as having hypertension if they had an untreated seated diastolic blood pressure (DBP) >100 mmHg, a DBP >90 mmHg with one or more antihypertensive medications, measured as the average of three readings with standard manual sphygmomanometer, or the use of two or more antihypertensive medications. Study procedures included dietary sodium modulation to maintain low-sodium (LS) and high-sodium balance (HS) in sequence.
Following the original study, 25OHD measurements were performed on the available frozen plasma of all subjects with hypertension. For the purpose of this current cross-sectional analysis, inclusion was restricted to nondiabetic Caucasians classified as having hypertension, successfully maintained in both HS and LS balance per study protocols, and with available 25OHD measurements (n = 223). This particular population of hypertensives was preselected from the overall HyperPath cohort since race [29] [30] [31] and diabetes 27, [32] [33] [34] may confound RAS physiology.
The HyperPath study protocol
The original HyperPath study protocol, which all subjects included in this analysis completed, was designed to minimise notable confounders of the RAS. To avoid interference with RAS assessment, participants taking angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or mineralocorticoid receptor antagonists, were withdrawn from these medications 3 months before study initiation. Beta-blockers were withdrawn 1 month before study initiation. If needed for blood pressure control, subjects were treated with amlodipine and/or hydrochlorothiazide; however, these medications were stopped 3 weeks prior to study initiation.
Following at least 3 weeks of full medication washout, subjects were maintained in LS (≤10 mmol/24 h), and then HS (≥200 mmol/24 h) for 5-7 days each with meals provided by the institutional Clinical Research Center (CRC). Both study diets also included fixed quantities of potassium (80 mmol/day) and calcium (1000 mg/day). After each diet phase, participants were admitted to the CRC and maintained in a supine position overnight. External sodium balance and diet compliance were confirmed upon admission to the CRC with a 24-h urine creatinine and sodium excretion of ≥150 mmol for HS, and ≤30 mmol for LS. For each diet phase, baseline blood sampling was obtained in the morning, stored at -20°C without preservatives until assayed, and used to measure PRA. Baseline blood pressure was determined while supine between the hours of 08:00 and 10:00, following 10 h of overnight rest using the average of five readings from a Dinamap automated device (Critikon, Tampa, FL, USA). Individuals who exhibited a ≥10 mmHg difference in SBP between HS and LS diets (HS SBP-LS SBP) were defined as having SS of BP. Those who exhibited a < 10 mmHg difference in SBP between diets were classified as having salt-resistant (SR) BP. The difference in SBP between HS and LS diets (ΔSBP) was also analysed as a continuous variable. Study protocols were approved by the Human Subjects Committees/Institutional Review Boards of each location, and informed written consent was obtained from each subject.
Biochemical assessments
All 223 subjects in this analysis had plasma 25OHD levels measured at baseline using the Diasorin corporation assay (Stillwater, MN, USA). PRA was measured in the morning following overnight supine rest on both LS and HS balance using the Diasorin assay. Per our prior convention, subjects whose PRA rose to 2.4 ng/mL/h or higher with upright posture in LS balance were defined as having normal-renin (NR) HTN, while those whose PRA remained less than 2.4 ng/mL/h were defined as low-renin (LR) HTN. 35, 36 All blood samples were processed and stored at one central laboratory (Brigham and Women's Hospital site).
Statistical methods
Analyses were performed to evaluate whether 25OHD was associated with PRA, and subsequently whether renin phenotype in HTN influenced the relationship between 25OHD and the BP response to dietary salt intake.
Demographic data are presented as mean values ± standard deviation (SD) for normally distributed data, median values and interquartile ranges for non-normally distributed data, or percentages for categorical data. Student's t-tests were used to compare means between independent populations with normal distributions, and the non-parametric Wilcoxon rank test was used for non-normally distributed data (PRA measurements). Fisher exact testing was used to detect statistical differences between categorical group frequencies. Multivariable linear regression was employed to test the continuous association between 25OHD and ΔSBP, and to test the relation between 25OHD and PRA, where 25OHD was categorised by clinically relevant values (<15, 15-30, ≥30 ng/mL).
Given prior suggestions that renin regulation in HTN may influence the association between vitamin D and the BP response to salt, 3, 4, 13, 14 we hypothesised that the relationship between 25OHD and ΔSBP may depend on renin status in HTN. Thus, we analysed this relationship according to renin status (LR or NR). To evaluate whether renin status was a significant effect modifier of the relationship between 25OHD and ΔSBP between HS and LS diets, we used a multivariable adjusted interaction model including age, sex, BMI, renin subgroup status (LR or NR), and an interaction term between 25OHD and renin subgroup status. The level for significance for all tests conducted was set at α = 0.05, with all reported p-values as two-tailed. Data analyses were performed using SAS statistical software, v9.1 (Cary, NC, USA).
Results
25OHD and PRA in the total study population
The mean 25OHD concentration in the total study population was in the insufficient range (22.5 ng/mL; SD = 8.8) based on current clinical consensus. 24 Approximately twothirds of the hypertensive population exhibited SS of BP, and as expected this group was associated with older age, female sex, and lower PRA, when compared to those with SR BP [37] [38] [39] [40] [41] (table 1) . There were no differences in 25OHD levels between SS groups in the total study population, which was comprised of heterogeneous renin phenotypes.
We investigated the relationship between 25OHD and PRA using linear regression. An inverse association between 25OHD status and PRA was observed in both HS and LS balance ( figure 1A,B ). After controlling for age, sex, BMI, and SBP in multivariable modelling, higher 25OHD concentrations continued to predict reduced PRA, and this relationship was independent of dietary sodium balance (p trend < 0.05 for HS and LS). 
25OHD and the pressor response to salt intake by renin status
Since the relationship between vitamin D and the BP response to salt was expected to be influenced by renin status, 3, 4, 13, 14 we analysed this relationship separately in the LR (n = 43) and NR (n = 180) HTN subgroups. Consistent with demographics in the entire study population, approximately two-thirds of each subgroup exhibited SS of BP (66% in LR, and 62% in NR). Individuals with LR were older than those with NR HTN (LR: 51.4 [SD = 6.2] vs. NR: 48.4 [SD = 8.4] years, p = 0.03), and with slightly The mean (SD) 25OHD levels in each of these categories was 11.5 (2.5), 22.9 (3.9), and 36.8 (6.9) ng/mL, respectively. In subjects with LR HTN, SS of BP was associated with significantly higher 25OHD levels in comparison to salt resistance ( figure 2A) . In contrast, salt-sensitive status displayed no association with 25OHD levels in subjects with NR HTN ( figure 2B ). These dichotomous relationships were further characterised using linear models that demonstrated a notable positive trend between increasing 25OHD concentrations and the pressor response to salt intake in the LR HTN subgroup (β = 0.54, p = 0.058) ( figure 3 ), but not in the NR HTN subgroup (β = 0.06, p = 0.59). After multivariable adjustment for age, sex, and BMI, 25OHD remained an independent and significant predictor of ΔSBP in subjects with LR HTN (β = 0.62, p = 0.04). This multivariable model accounted for 15.1% of the variability in ΔSBP, with 25OHD explaining more than two-thirds of the variance in ΔSBP (table 2). When the interaction between renin subgroup status and 25OHD was evaluated in an adjusted interaction model, renin status was a significant effect modifier of the relationship between 25OHD and the BP response to salt intake (p = 0.04).
Discussion
Extending the work of others, we hypothesised that 25OHD, the precursor to active 1,25OHD and clinically relevant marker of vitamin D status, would be associated with plasma renin activity independent of salt status. Furthermore, we evaluated whether 25OHD was associated with the pressor response to salt by renin subgroups in HTN. In this cross-sectional study, we analysed Caucasian subjects with HTN, off all BP medications, and evaluated for salt sensitivity of BP after maintenance in HS and LS balance. We observed that increasing 25OHD concentrations were associated with lower PRA under both salt conditions, and additionally noted a significant positive relationship between 25OHD and the BP response to salt that was dependent on LR status. These findings support the hypotheses that vitamin D may function as an inhibitor of renin production, and play a role in determining the pressor response to salt.
Our findings are consistent with and extend the work of others. First, we observed a significant, and independent, inverse relationship between increasing 25OHD concentrations and PRA. These findings are notable in supporting prior human investigations implicating vitamin D in the regulation of renin, 3, 4, 6 and animal studies strongly suggesting that vitamin D behaves as an endogenous inhibitor of renin expression. 17, 18 Similar to our observations, Tomaschitz et al. recently demonstrated an inverse relationship between plasma renin concentrations and both 25OHD and 1,25OHD after multivariable adjustments; 42 however, subjects in that cross-sectional study were of mixed HTN and diabetes status, and were analysed on ad lib antihypertensive therapy and ad lib dietary sodium, all of which are significant confounders of the RAS. Our findings substantiate their observations as we exclusively studied non-diabetic subjects with HTN, withdrawn from antihypertensive medications, and maintained in strict sodium balance and fixed dietary calcium. In this manner, we detected an inverse relationship between 25OHD and PRA that was evident irrespective of the controlled sodium intake. We also employed multivariable linear regression to control for potentially confounding variables. This finding may have notable implications for clinical medicine; if vitamin D is in the causal pathway to lower PRA, it could be beneficial in treatment of hypertension, cardiovascular and renal diseases. 6, 43, 44 Prior investigators proposed that the relationship between calcium-vitamin D homeostasis and BP may be most evident in LR HTN. 13, 14 Given this observation, and that vitamin D concentrations are inversely associated with PRA and renin phenotype status, 3, 4, 42 we subsequently evaluated the relationship between 25OHD and the pressor response to salt. Based on the expectation that a notable association between 25OHD and ΔSBP may not be evident in the combined population where renin phenotypes are heterogeneous, we analysed this relationship separately in the renin subgroups which were defined via a dichotomous response by PRA to upright posture in LS, as per our prior convention. 35, 36 Higher 25OHD concentrations in LR HTN were independently associated with increased pressor responses to salt; this association was absent in NR HTN. After multivariable analysis, the positive association between 25OHD and the pressor response to salt in the LR subgroup was only marginally significant (p = 0.04); this may have been a ramification of our small sample size (n = 43). However, when evaluated quantitatively in an adjusted interaction model including all 223 subjects, renin status was a significant effect modifier of the relationship between 25OHD and the change in SBP with salt. This may support the possibility that vitamin D may interact with the RAS to predict the pressor response to salt.
Despite consistent observations establishing salt sensitivity of BP as a prevalent phenotype in HTN, the pathophysiology of the pressor response to salt remains poorly understood. Prior studies suggest that the BP response to salt is dependent on an interaction between the RAS and vitamin D that determines vascular smooth muscle calcium concentrations, and consequently smooth muscle contractility and vascular tone. 7, 8, 10, 12 Salt-induced BP elevations have been associated with salt-induced increases in 1,25OHD levels; salt loading results in an increased production of active vitamin D in those individuals who display SS of BP. [3] [4] [5] Furthermore, the observation that calcium concentrations within juxtaglomerular cells inhibit renin release provides another mechanism supporting the association between vitamin D concentrations and low-renin status and reduced activity of renin. 3, 4, 15, 16 At first glance, our current findings associate higher vitamin D status with lower PRA but also increased SS of BP in this low-renin setting, suggesting that suppression of the RAS and sodium retention is associated with higher 25OHD levels. This interpretation may contradict emerging hypotheses that higher vitamin D concentrations reduce BP. 6, 45, 46 However, the exact relationship between vitamin D, the RAS, sodium balance, and vascular smooth muscle tone may not be this simple, and likely involves many factors implicated by others, but not investigated in our study (ionised calcium, intracellular and extracellular calcium concentrations, parathyroid hormone, and 1,25OHD) [3] [4] [5] 10, 12, 13, [47] [48] [49] Additionally, Imaoka et al. observed that hypertensive women had lower PRA when compared to normotensive women, but also lower 25(OH)D levels; they did not see the same inverse relationship between 25(OH)D and PRA we did. 50 However, the findings of Imaoka et al. may not directly translate to ours since they compared hypertensive women with normotensives, while we specifically focused within the hypertensive phenotype. Although these prior studies proposed a unique and complex interplay between calcium-regulating and sodium-regulating hormones, it remains to be determined whether the actions of vitamin D in this process are to promote, or inhibit, hypertension. Rather, the sum of prior evidence is limited to suggesting that intracellular calcium concentrations may be influenced by vitamin D and the RAS, and this interface is fundamental in determining renin activity and the BP response to salt. 8, 11, 12, 15, 16 Our results may shed light on the interaction between salt, calcium, the RAS, and calcium-regulating hormones in predicting BP: the pressor response to salt may depend on a low renin state combined with sufficient vitamin D availability. Furthermore, the concept that LR HTN is strongly associated with salt sensitivity of BP may need to be reevaluated to include consideration of vitamin D and calcium homeostasis. 1 Our findings are notable in that they associate 25OHD with the same parameters previously associated with 1,25OHD (PRA and SS of BP) and with the same direction of association. In this regard, 25OHD and 1,25OHD may both serve as barometers of vascular tone in the setting of salt-loading conditions in HTN.
Our results must be interpreted within the context of our study design. First, this analysis was cross-sectional, and thus cannot prove causality or directionality of associations. Our study was not designed to distinguish the mechanism by which vitamin D influences PRA or SS of BP; it provides association data supporting vitamin D as a potential inhibitor of renin production and again implicates it in the complex relationship between dietary sodium and BP. Whether vitamin D supplementation dampens or enhances the pressor response to salt is unclear; our findings merely suggest that an interplay between these factors may exist, and warrants more investigation. Although we demonstrated continuous associations between 25OHD and PRA, and between 25OHD and the ΔSBP in LR HTN, we are aware that our phenotyping convention used to define LR and NR status may differ from those used by others; thus our findings may not directly translate to other classifications of LR HTN.
Parathyroid hormone has been associated with HTN, vascular disease, and the RAS; 51-56 however, whether its role is independent of vitamin D metabolites remains unresolved. 57 Our study design controlled for dietary sodium and calcium intake, but we did not have ionised calcium, parathyroid hormone, or 1,25OHD measurements that could have shed further insight on potential interacting mechanisms with the RAS and SS HTN, and thus cannot comment on whether our observed association were independent of these factors. However, our findings support prior observations, and raise new questions into the interplay between vitamin D, the RAS, and BP responses to salt. The generalisability of our findings is limited to the population we analysed, a relatively homogenous group of hypertensive Caucasians without diabetes; this demographic restriction allowed for more reliable results since race [29] [30] [31] and diabetes 27, [32] [33] [34] are potential confounders of the RAS. Though our study design controlled for many major confounders of the RAS, several other factors that are known (oestrogen status, stress, sympathetic nervous system activity) or unknown to affect the RAS may have influenced our measurements. 58, 59 We have previously observed similar inverse associations between increasing 25OHD and PRA that were not statistically significant; this discrepancy may be due to the fact that they were performed in smaller sample sizes with log linear analyses, and in a population of normotensives in contrast to our current focus on hypertensives. 21, 22 
Conclusions
Although the pressor response to salt remains a poorly understood phenomenon, suggestive evidence implicates an interaction between the RAS and calcium-regulating hormones in the mechanism of SS of BP. Vitamin D metabolites, including 25OHD, are inversely associated with PRA and additionally may be involved in determining the BP response to salt in LR hypertensives. The classification of SS of BP in HTN may warrant consideration of calcium and vitamin D status in addition to salt balance and evaluation of the RAS, especially in LR HTN. Future studies to investigate these complex and evolving relationships are needed.
